These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8750842)

  • 1. Fos is not involved in the regulation of the proenkephalin gene by haloperidol in the mouse striatum.
    Ziółkowska B; Höllt V
    Brain Res Mol Brain Res; 1995 Dec; 34(2):351-4. PubMed ID: 8750842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J; Pietraszek M; Dziedzicka-Wasylewska M
    Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum.
    Ziólkowska B; Höllt V
    Neurosci Lett; 1993 Jun; 156(1-2):39-42. PubMed ID: 8414186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of proenkephalin and prodynorphin genes and the induction of c-fos gene by dopaminergic drugs are not altered in the straitum of MPTP-treated mice.
    Ziolkowska B; Horn G; Kupsch A; Höllt V
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):151-64. PubMed ID: 8527000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.
    Wardas J; Pietraszek M; Wolfarth S; Ossowska K
    Neuroscience; 2003; 122(3):747-56. PubMed ID: 14622918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acute and chronic 1,2,3,4-tetrahydroisoquinoline administration on the expression of proenkephalin mRNA in the rat striatum.
    Wardas J; Zapała M; Lorenc-Koci E
    Pol J Pharmacol; 2003; 55(6):951-6. PubMed ID: 14730088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons.
    Dragunow M; Robertson GS; Faull RL; Robertson HA; Jansen K
    Neuroscience; 1990; 37(2):287-94. PubMed ID: 1966822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance between striatal expression of Fos, proenkephalin mRNA, prodynorphin mRNA and rotation induced by l-stepholidine in 6-hydroxydopamine-lesioned rats.
    Ding YM; Tang FM; Yu LP; Fu Y; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Oct; 21(10):885-92. PubMed ID: 11501038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum.
    Konradi C; Kobierski LA; Nguyen TV; Heckers S; Hyman SE
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7005-9. PubMed ID: 8346209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
    Gnegy ME; Hewlett GH; Pimputkar G
    Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.
    Morris BJ; Höllt V; Herz A
    Neuroscience; 1988 May; 25(2):525-32. PubMed ID: 3041310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol.
    Boegman RJ; Vincent SR
    Synapse; 1996 Jan; 22(1):70-7. PubMed ID: 8822480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment.
    Jolkkonen J; Jenner P; Marsden CD
    Neurosci Lett; 1994 Oct; 180(2):273-6. PubMed ID: 7535410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.